Compare APP & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APP | MDT |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.6B | 131.9B |
| IPO Year | 2021 | 2014 |
| Metric | APP | MDT |
|---|---|---|
| Price | $463.04 | $89.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 19 |
| Target Price | ★ $703.71 | $109.82 |
| AVG Volume (30 Days) | 5.6M | ★ 7.9M |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | ★ 115.23 | 30.80 |
| EPS | ★ 9.75 | 2.76 |
| Revenue | $5,480,717,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $47.55 | $8.91 |
| Revenue Next Year | $29.08 | $6.75 |
| P/E Ratio | $49.00 | ★ $32.65 |
| Revenue Growth | ★ 16.38 | 3.62 |
| 52 Week Low | $200.50 | $79.55 |
| 52 Week High | $745.61 | $106.33 |
| Indicator | APP | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 25.36 |
| Support Level | $344.94 | $88.29 |
| Resistance Level | $473.69 | $93.13 |
| Average True Range (ATR) | 26.44 | 1.83 |
| MACD | 12.93 | -0.88 |
| Stochastic Oscillator | 62.11 | 8.79 |
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.